NCT01444612 - Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | Biotech Hunter

Enrollment

4,068

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions

Thrombosis, Venous

Interventions

DRUG

dalteparin

An injectable anticoagulant medication for the prevention of VTE related to cancer surgery. Patients received dalteparin during one day prior to or two days after cancer-related surgery during the hospitalization.

DRUG

enoxaparin

An injectable anticoagulant medication for the prevention of VTE related to cancer surgery. Patients received enoxaparin during one day prior to or two days after cancer-related surgery during the hospitalization.

DRUG

fondaparinux

An injectable anticoagulant medication for the prevention of VTE related to cancer surgery. Patients received fondaparinux during one day prior to or two days after cancer-related surgery during the hospitalization.

DRUG

unfractionated heparin

An injectable anticoagulant medication for the prevention of VTE related to cancer surgery. Patients unfractionated heparin received during one day prior to or two days after cancer-related surgery during the hospitalization.